VarmX Partners With Biotech CSL In Deal Worth Up To $2.2B

By Jade Martinez-Pogue · September 16, 2025, 1:18 PM EDT

European life sciences venture capital firm EQT Life Sciences on Tuesday announced that its portfolio company VarmX, a Netherlands-based biotech, has entered into an exclusive option agreement to be bought by...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login